Skip to main content
. 2018 Aug 28;8:12968. doi: 10.1038/s41598-018-29692-0

Figure 1.

Figure 1

The Schematic diagram of triptolide prodrug (A) and redox-responsive self-assembly PEG nanoparticle for antitumor of triptolide (B). (a) antitumor effect in terms of tumor growth (error bars are mean ± SD, n = 10); (b) the change of body weight during the treatments; (c) tumor growth after systemic application of different treatment groups; (d) tumor weight (error bars are mean ± SD, n = 10).